cognitive

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced

Supreme Origin CBD Coffee Now Available in the U.S.

Supreme Origin Tolima “As a coffee expert, I saw this opportunity to blend my passion for wellness and coffee into a great new brand looking to reshape how we experience our favorite morning beverage,” Shattah says. DENVER (PRWEB) November 03, 2021 World-renowned infused coffee Supreme Origin arrives in the United States in time for the holiday season with 20 percent off for new subscribers and free shipping nationwide in November. Help coffee-loving friends and family perk up and relax this holiday season with the gift of great-tasting CBD-infused coffee for

Unraveling the Blockchain and Crypto Gaming World One Click at a Time

Regular readers will no doubt be aware of the high expectations currently being placed on the shoulders of blockchain gaming. For advocates of blockchain technology, there is the hope that tapping into the estimated 2.5 billion gamers worldwide will provide a huge leap toward mainstream adoption.Blockchain and distributed ledger technology continue to make inroads into all kinds of industries as an increasing number of people discover and gain an understanding of the benefits that it can bring. From supply chain efficiencies through certification of authenticity and provenance to the immutable